Thermo Fisher Scientific Thermo Fisher Scientific is a biotechnology company engaged in service science. | Santa Cruz Biotechnology Santa Cruz Biotechnology (SCBT) is a company engaged in the development of products for the biomedical research market. | Rockland Immunochemicals Rockland Immunochemicals is a biotech company that designs, produces, validates, and delivers antibodies and life science reagents for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. | Merck Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals. | Bio-Techne Bio-Techne is a company that provides researchers in life science and clinical diagnostics with reagent instruments, custom manufacturing, and testing services. | ||
Founding Date | Founding Date 2002 | Founding Date 1956 | Founding Date 1991 | Founding Date 1962 | Founding Date 1891 | Founding Date 1981 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | ||||||
Locations | Locations San Diego, US HQ Beijing, CN Koblenz, DE Bunkyo City, JP Amsterdam, NL London, GB | Locations Waltham, US HQ Buenos Aires, AR Buenos Aires, AR Buenos Aires, AR Adelaide Airport, AU Brendale, AU Canberra, AU see more | Locations Dallas, US HQ Shanghai, CN Heidelberg, DE Paso Robles, US Santa Cruz, US Sun Valley, US | Locations HQ | Locations Rahway, US HQ Hydra, DZ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE see more | Locations Minneapolis, US HQ Toronto, CA Praha, CZ Copenhagen, DK Noyal Châtillon Sur Seiche, FR Noyal Châtillon Sur Seiche, FR Planegg, DE see more |
Employees | Employees 6771% increase | Employees 122,0006% decrease | Employees 1692% decrease | Employees 1021% decrease | Employees 72,0007% increase | Employees 3,0502% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 229.5 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 294.7 b | Valuation ($) 11.9 b |
Financial | ||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $42.9b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $60.1b (FY, 2023) | Revenue (est.) $1.2b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $25.8b (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods $16.1b (FY, 2023) | Cost of goods $389.3m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $17.1b (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit $44b (FY, 2023) | Gross profit $769.7m (FY, 2024) |
Net income | Net income N/A | Net income $6b (FY, 2023) | Net income N/A | Net income N/A | Net income $377m (FY, 2023) | Net income $168.1m (FY, 2024) |